Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Coghill AE et al. |
Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. |
2016 |
Am. J. Transplant. |
pmid:26824445
|
Egli A et al. |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. |
2010 |
Am. J. Transplant. |
pmid:20840474
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Duncan FJ et al. |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. |
2007 |
Am. J. Transplant. |
pmid:17941958
|
Silva HT et al. |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:24266969
|
Ricciardelli I et al. |
Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. |
2013 |
Am. J. Transplant. |
pmid:24266973
|
Hu X et al. |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell-Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats. |
2016 |
Am. J. Transplant. |
pmid:26749344
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Cameron AM et al. |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine. |
2016 |
Am. J. Transplant. |
pmid:26748958
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Vanrenterghem Y et al. |
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. |
2005 |
Am. J. Transplant. |
pmid:15636615
|
Bryan CF et al. |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. |
2007 |
Am. J. Transplant. |
pmid:17359511
|
Vincenti F et al. |
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. |
2007 |
Am. J. Transplant. |
pmid:17359512
|
Diaz-Siso JR et al. |
Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. |
2015 |
Am. J. Transplant. |
pmid:25777324
|
Cendales L et al. |
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. |
2015 |
Am. J. Transplant. |
pmid:25773260
|
Klintmalm GB et al. |
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. |
2014 |
Am. J. Transplant. |
pmid:25041339
|
Jaksch P et al. |
Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. |
2014 |
Am. J. Transplant. |
pmid:25039364
|
TruneÄŒka P et al. |
Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. |
2015 |
Am. J. Transplant. |
pmid:25707487
|
Adam R et al. |
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. |
2015 |
Am. J. Transplant. |
pmid:25703527
|
Asrani SK and O'Leary JG |
Can one pill a day keep rejection away? |
2015 |
Am. J. Transplant. |
pmid:25703394
|
Bhorade SM et al. |
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. |
2003 |
Am. J. Transplant. |
pmid:14629288
|
Madeleine MM et al. |
HPV-related cancers after solid organ transplantation in the United States. |
2013 |
Am. J. Transplant. |
pmid:24119294
|
Oetting WS et al. |
Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles. |
2016 |
Am. J. Transplant. |
pmid:26485092
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Badri P et al. |
Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir. |
2015 |
Am. J. Transplant. |
pmid:25708713
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Carenco C et al. |
Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship. |
2015 |
Am. J. Transplant. |
pmid:25648361
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Schrepfer S et al. |
Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. |
2007 |
Am. J. Transplant. |
pmid:17532751
|
Asberg A et al. |
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20486914
|
Hautz T et al. |
Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. |
2010 |
Am. J. Transplant. |
pmid:20353468
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Haufroid V et al. |
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. |
2006 |
Am. J. Transplant. |
pmid:17049058
|
Lake JR et al. |
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:16303011
|
Mandelbrot DA et al. |
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus. |
2015 |
Am. J. Transplant. |
pmid:26176342
|